Interviews

MEDSIR (Medica Scientia Innovation Research) is an international company, based in Barcelona and New Jersey, specializing in the design and …

As the demand for decentralized and hybrid clinical trials rises, Medable Inc. is positioning itself at the forefront of this …

The rapid convergence of artificial intelligence (AI) and synthetic biology (synbio) is set to revolutionize a multitude of industries, ranging …

Toronto-based “techbio” company Deep Genomics has just annouced major milestones with the opening of a new office and lab facility …

The integration of artificial intelligence (AI) in biotech is not just enhancing the efficiency of processes but is also enabling …

In an industry as critical as clinical trials, where efficient data management and swift processes are paramount, outdated tech methods …

My interview with Mirit Eldor, Managing Director, Life Sciences Solutions, at Elsevier, as we discuss Elsevier's recent collaboration with gen …

In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia …

As we stand at the crossroads of artificial intelligence (AI) and biotech, what future awaits protein design, and how are …

In this episode, I dive deep into the burgeoning digital health landscape of the United Arab Emirates, a region rapidly …

The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …

Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …